Sexual Health | Bacterial STIs and related conditions | Chlamydia Trachomatis: Natural History and Management
Chlamydia Trachomatis: Natural History and Management
Session Overview
Description
This session covers the pathogenesis and management of uncomplicated genital chlamydia, including antibiotic choice and appropriate advice and partner notification. The level is suitable for enhanced practitioners.
Learning Objectives
By the end of this session you will be able to:
- Describe the pathogenesis of infections by Chlamydia trachomatis, including life-cycle, virulence and host-defence mechanisms
- List uncomplicated presentations of chlamydia genital tract infection
- Manage chlamydia genital tract infection by identifying appropriate choice of antibiotics for the condition
- Give appropriate information to patients diagnosed with chlamydia regarding treatment, partner notification and sexual abstinence
Chlamydia trachomatis is a Gram-negative obligate bacterium belonging to the genus Chlamydia in the family Chlamydiaceae.
Genital infection with Chlamydia trachomatis is one of the most common bacterial sexually transmitted infections.
The World Health Organisation estimates at least 90 million annual cases worldwide. More than 100,000 cases are diagnosed in the UK each year.
The primary anatomic sites of infection are the urethra only in heterosexual men and the urethra, rectum and pharynx in men who have sex with men. In women, the uterine cervix and urethra are most commonly infected; however, rectal infections are increasingly recognized in women.
Ascending infection from the cervix to the uterine body and Fallopian tubes may result in pelvic inflammatory disease (PID), which may carry significant morbidity and potential mortality from ectopic pregnancy as well as causing chronic pelvic pain.
Chlamydial PID can lead to scarring or blockage of the tubes, and is one of the most common causes of female infertility.
Since there may be few outward symptoms, chlamydia diagnosis and treatment can often be delayed, increasing the risk of long-term complications.
- End of Life Care | Advance care planning | Advance...
- Posted By eIntegrity Healthcare e-Learning
- Posted Date: 2026-02-07
- Location:Online
- This session focuses on principles of good practice which underpin the appropriate and valid use of Advance Decisions to Refuse Treatment (ADRT), within an end of life care context. This session was reviewed by Fiona Rawlinson and Sarah Hanrott and last u
- End of Life Care | Advance care planning | Advance...
- Posted By eIntegrity Healthcare e-Learning
- Posted Date: 2026-02-07
- Location:Online
- This session builds on the principles of advance decisions to refuse treatment. It focuses on the practical steps involved in supporting patients requesting the development of an advance decision. This session was reviewed by Fiona Rawlinson and Sarah Han
- End of Life Care | Advance care planning | ACP in ...
- Posted By eIntegrity Healthcare e-Learning
- Posted Date: 2026-02-07
- Location:Online
- This session describes how the Preferred Priorities for Care tool may be used to facilitate advance care planning. This session was reviewed by Fiona Rawlinson and Sarah Hanrott, and last updated in February 2023.
- End of Life Care | Advance care planning | ACP and...
- Posted By eIntegrity Healthcare e-Learning
- Posted Date: 2026-02-07
- Location:Online
- This session provides an overview of the concept of illness trajectories and its influence on the advance care planning (ACP) process in end of life care. This session was reviewed by Fiona Rawlinson and Sarah Hanrott and last updated in February 2023.
- Acquired Brain Injury course
- Posted By eIntegrity Healthcare e-Learning
- Posted Date: 2026-02-06
- Location:Online
- This session will outline the causes and effects of acquired brain injury (ABI) in childhood. It wil...